Harbin Pharmaceutical Group Co., Ltd. (SHA:600664)
China flag China · Delayed Price · Currency is CNY
3.490
+0.030 (0.87%)
Feb 3, 2026, 3:00 PM CST

SHA:600664 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
15,88416,11915,40013,75512,74110,741
Other Revenue
56.8356.8356.2153.6361.0647.59
15,94116,17615,45713,80912,80210,788
Revenue Growth (YoY)
-1.72%4.65%11.93%7.86%18.66%-8.76%
Cost of Revenue
11,75111,65511,44310,4469,8268,543
Gross Profit
4,1894,5214,0133,3632,9762,245
Selling, General & Admin
3,2333,3903,1432,5652,3062,824
Research & Development
149.04136.43106.02115.8197.7392.53
Other Operating Expenses
143.1108.29120.17122.65113.17104.39
Operating Expenses
3,6023,6713,3952,8052,5283,049
Operating Income
587.25849.71618.44557.91447.79-803.3
Interest Expense
-50.06-60.07-56.47-85.53-105.16-58.27
Interest & Investment Income
31.3749.4751.5869.1916.550.42
Currency Exchange Gain (Loss)
-5.68-5.68-5.3731.99-0.83
Other Non Operating Income (Expenses)
70.7266.61-22.74-19.44-5.07-176.52
EBT Excluding Unusual Items
633.6900.04585.45525.13356.06-988.49
Gain (Loss) on Sale of Investments
----20--
Gain (Loss) on Sale of Assets
4.320.940.98161.38210.8714.1
Asset Writedown
-64.32-59.84-15.13-32.52-2.33-74.72
Other Unusual Items
71.7533.8779.2567.1765.9380.47
Pretax Income
645.35875.01650.54701.15630.53-968.65
Income Tax Expense
160.8184.4176.32188.94220.6976.6
Earnings From Continuing Operations
484.55690.61474.22512.21409.85-1,045
Minority Interest in Earnings
-35.4-61.76-78.95-47.06-38.76-32.45
Net Income
449.15628.85395.26465.15371.08-1,078
Net Income to Common
449.15628.85395.26465.15371.08-1,078
Net Income Growth
-26.73%59.10%-15.02%25.35%--
Shares Outstanding (Basic)
2,5052,5152,4702,4482,4742,506
Shares Outstanding (Diluted)
2,5052,5152,4702,5842,4742,506
Shares Change (YoY)
-2.18%1.82%-4.40%4.46%-1.29%-10.19%
EPS (Basic)
0.180.250.160.190.15-0.43
EPS (Diluted)
0.180.250.160.180.15-0.43
EPS Growth
-25.10%56.25%-11.11%20.00%--
Free Cash Flow
172.54691.69863.14532.45-239.13-846.37
Free Cash Flow Per Share
0.070.280.350.21-0.10-0.34
Gross Margin
26.28%27.95%25.96%24.35%23.24%20.81%
Operating Margin
3.68%5.25%4.00%4.04%3.50%-7.45%
Profit Margin
2.82%3.89%2.56%3.37%2.90%-9.99%
Free Cash Flow Margin
1.08%4.28%5.58%3.86%-1.87%-7.85%
EBITDA
770.891,066878.27821.32716.99-433.54
EBITDA Margin
4.84%6.59%5.68%5.95%5.60%-4.02%
D&A For EBITDA
183.64216.29259.83263.41269.2369.75
EBIT
587.25849.71618.44557.91447.79-803.3
EBIT Margin
3.68%5.25%4.00%4.04%3.50%-7.45%
Effective Tax Rate
24.92%21.07%27.10%26.95%35.00%-
Revenue as Reported
15,94116,17615,45713,80912,80210,788
Advertising Expenses
-1,8061,5741,058340.89201.29
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.